O
33
2
MAR
71
3
KIM
50
-3
PYPL
52
2
EXPD
51
16
PNR
51
3
AVB
34
-3
FSLR
73
15
GD
62
5
HRB
46
4
ALL
56
2
EW
58
5
GM
85
2
NOV
52
4
MTB
73
4
CI
48
-4
HAL
50
2
MHK
43
-2
GILD
56
6
CSCO
64
6
O
33
2
MAR
71
3
KIM
50
-3
PYPL
52
2
EXPD
51
16
PNR
51
3
AVB
34
-3
FSLR
73
15
GD
62
5
HRB
46
4
ALL
56
2
EW
58
5
GM
85
2
NOV
52
4
MTB
73
4
CI
48
-4
HAL
50
2
MHK
43
-2
GILD
56
6
CSCO
64
6
Financhill
Back

Calidi Biotherapeutics, Inc. 10K Form

Sell
24

CLDI
Calidi Biotherapeutics, Inc.

Last Price:
$1.36
Seasonality Move:
-32.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLDI News And Ratings

See the #1 stock for the next 7 days that we like better than CLDI

CLDI Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-4.3M
Price / Cash Flow: 0
Annual Sales: $1.00
Price / Book: 1.41

Profitability

EPS (TTM): -6.74420
Net Income (TTM): $-25.8M
Gross Margin: $-1.5M
Return on Equity: -1476.9%
Return on Assets: -217.81%

Calidi Biotherapeutics, Inc. Earnings Forecast

Key Calidi Biotherapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 5 years have been positive in 2 years.

Calidi Biotherapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: CLDI
Website: calidibio.com

Debt

Debt-to-Equity Ratio: 0.48
Current Ratio: 2.12
Quick Ratio: 2.02

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CLDI Technical Analysis vs Fundamental Analysis

Sell
24
Calidi Biotherapeutics, Inc. (CLDI) is a Sell

Is Calidi Biotherapeutics, Inc. a Buy or a Sell?